Genetic Analysis
0.61 NOK
-9.63 %
Less than 1K followers
GEAN
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-9.63 %
-6.15 %
-12.86 %
-17.57 %
-30.68 %
+5.17 %
-66.99 %
-
-94.30 %
Genetic Analysis operates in the medical technology sector. The company conducts research and development in the field of diagnostics, with the greatest focus on the human microbiome. The technology is based on the company's research platform and the IVD products are used, for example, for testing and analysis of bacteria and viruses. The largest operations are found in the Nordic market and the products are mainly resold to laboratories. The company is headquartered in Oslo, Norway.
Read moreMarket cap
42.14M NOK
Turnover
17.94K NOK
Revenue
16.71M
EBIT %
-67.4 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
All
Press releases
3rd party
ShowingAll content types
Analyst Group: Equity Research Report on Genetic Analysis - Sustained Long-Term Growth Outlook Supported by Platform Strategy
Analyst Group: Analyst Group Comment on Genetic Analysis Q4-report Report 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools